Exome Sequencing Reveals Misdiagnoses in Epidermolysis Bullosa Patients
A Brazilian sequencing program for EB patients brings access to more accurate diagnoses and better treatment
A Brazilian sequencing program for EB patients brings access to more accurate diagnoses and better treatment
How genomics provided critical answers—and in record time—to transform outcomes for a newborn and his family
An Illumina iConserve project is mapping genetic diversity to identify where confiscated gorillas come from and boost survival rates
Immunodiagnostics company Verici Dx leverages AI workflows in Illumina Connected Analytics for transplant prognosis
Biobot Analytics is using wastewater data to predict COVID surges and other outbreaks
日付 | 論文 | タイトル |
---|---|---|
2021/02/25 | Kaiser Health News | Have a Case of a Covid Variant? No One Is Going to Tell You |
2021/02/25 | BioPharma Reporter | German program using whole genome sequencing to diagnose rare diseases and cancer risk |
2021/02/17 | Cambridge Independent | Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge |
2021/02/17 | Bloomberg Technology | Illumina's deSouza on Tech Growth and Need for a Bio Force |
2021/02/17 | Associated Press | Government rushes virus gene-mapping as mutations spread |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.